Plans revealed for Alderley Park Cheshire

Manchester Science Partnerships (MSP) has revealed plans for the first phase of development at its 400-acre life science campus at Alderley Park in Cheshire.

The BDP designed proposals, which were revealed at MIPIM, centre on the redevelopment of existing buildings vacated by AstraZeneca, the former site owner, and signal the first major step for MSP’s vision to transform Alderley Park into a thriving open innovation community for life science businesses with over 7,000 high-value jobs planned on-site in the next decade.

One of the first major redevelopments for MSP, and its lead property partner Bruntwood, is the redesign of a four-storey building, transforming a previously unloved AstraZeneca lab facility into a 300,000 sq ft centre for innovative and ambitious businesses. The centre will include a variety of workspaces from high-end specialist labs to flexible offices and manufacturing facilities. Designs will focus on a new communal atrium and internal courtyard featuring new meeting and conference facilities with views over the Alderley Park woodland. New entrances with a strong visual impact will open up the building and the plans will also feature opportunities for retail and café facilities.

BDP is also working on a £10m hub building for MSP at the centre of Manchester Science Park which started on site in January, as well as being lead consultant for AstraZeneca’s new Global R&D centre and Corporate Headquarters in Cambridge.